Ideaya Biosciences Stock Cash Flow From Operations
| IDYA Stock | USD 26.60 1.06 4.15% |
Ideaya Biosciences fundamentals help investors to digest information that contributes to Ideaya Biosciences' financial success or failures. It also enables traders to predict the movement of Ideaya Stock. The fundamental analysis module provides a way to measure Ideaya Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ideaya Biosciences stock.
Ideaya | Cash Flow From Operations |
Ideaya Biosciences Company Cash Flow From Operations Analysis
Ideaya Biosciences' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Ideaya Biosciences Cash Flow From Operations | (115.22 M) |
Most of Ideaya Biosciences' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ideaya Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Ideaya Cash Flow From Operations Driver Correlations
Understanding the fundamental principles of building solid financial models for Ideaya Biosciences is extremely important. It helps to project a fair market value of Ideaya Stock properly, considering its historical fundamentals such as Cash Flow From Operations. Since Ideaya Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ideaya Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ideaya Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Ideaya Biosciences has (115.22 Million) in Cash Flow From Operations. This is 121.85% lower than that of the Biotechnology sector and 284.29% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 111.86% higher than that of the company.
Ideaya Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ideaya Biosciences' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ideaya Biosciences could also be used in its relative valuation, which is a method of valuing Ideaya Biosciences by comparing valuation metrics of similar companies.Ideaya Biosciences is currently under evaluation in cash flow from operations category among its peers.
Ideaya Biosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Ideaya Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Ideaya Biosciences' managers, analysts, and investors.Environmental | Governance | Social |
Ideaya Fundamentals
| Return On Equity | -0.21 | ||||
| Return On Asset | -0.16 | ||||
| Operating Margin | (57.31) % | ||||
| Current Valuation | 1.31 B | ||||
| Shares Outstanding | 86.43 M | ||||
| Shares Owned By Insiders | 1.03 % | ||||
| Shares Owned By Institutions | 98.97 % | ||||
| Number Of Shares Shorted | 9.31 M | ||||
| Price To Earning | (2.17) X | ||||
| Price To Book | 1.87 X | ||||
| Price To Sales | 586.20 X | ||||
| Revenue | 23.39 M | ||||
| Gross Profit | (38.6 M) | ||||
| EBITDA | (130.42 M) | ||||
| Net Income | (112.96 M) | ||||
| Cash And Equivalents | 268.62 M | ||||
| Cash Per Share | 6.83 X | ||||
| Total Debt | 2.87 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 4.69 X | ||||
| Book Value Per Share | 13.67 X | ||||
| Cash Flow From Operations | (115.22 M) | ||||
| Short Ratio | 12.62 X | ||||
| Earnings Per Share | (2.33) X | ||||
| Target Price | 54.87 | ||||
| Number Of Employees | 124 | ||||
| Beta | 0.86 | ||||
| Market Capitalization | 2.3 B | ||||
| Total Asset | 649.32 M | ||||
| Retained Earnings | (348.36 M) | ||||
| Working Capital | 505.53 M | ||||
| Current Asset | 93.24 M | ||||
| Current Liabilities | 6.51 M | ||||
| Net Asset | 649.32 M |
About Ideaya Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ideaya Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ideaya Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ideaya Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ideaya Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ideaya Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ideaya Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ideaya Biosciences Stock:Check out Ideaya Biosciences Piotroski F Score and Ideaya Biosciences Altman Z Score analysis. For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ideaya Biosciences. If investors know Ideaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ideaya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.33) | Revenue Per Share 0.051 | Quarterly Revenue Growth (0.03) | Return On Assets (0.16) | Return On Equity (0.21) |
The market value of Ideaya Biosciences is measured differently than its book value, which is the value of Ideaya that is recorded on the company's balance sheet. Investors also form their own opinion of Ideaya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ideaya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ideaya Biosciences' market value can be influenced by many factors that don't directly affect Ideaya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ideaya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ideaya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ideaya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.